LPGL financials Leiner Pak Gelatine Limited
Leiner Pak Gelatine Limited (LPGL) has 5 financial years on file, from the year to 30 Jun 2022. The latest, the year to 30 Jun 2026 earned Rs 0.04 a share on sales of Rs 1.6 bn. 5 quarters are listed below the years.
Results by financial year
Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 30 June. 5 years and 5 of the last 8 quarters.
Earnings per share by financial year
| Year | Earnings per share (Rs) | Sales | Gross margin | Net profit as a share of sales | Change in earnings per share on the year before |
|---|---|---|---|---|---|
| Year to 30 Jun 2026 | 0.04 | Rs 1.6 bn | 12.0% | 0.0% | -98.1% |
| Year to 30 Jun 2025 | 2.11 | Rs 1.6 bn | 16.8% | 1.0% | -80.6% |
| Year to 30 Jun 2024 | 10.87 | Rs 3.3 bn | 12.5% | 2.4% | +22.3% |
| Year to 30 Jun 2023 | 8.89 | Rs 2.3 bn | 15.8% | 2.9% | +708.2% |
| Year to 30 Jun 2022 | 1.10 | Rs 1.0 bn | 14.3% | 0.8% | — |
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 0.04 | Rs 112.6 m | — | — | -87.9% |
| Quarter to 31 Mar 2026 | 0.17 | Rs 375.2 m | — | — | -26.1% |
| Quarter to 31 Dec 2025 | 3.85 | Rs 460.1 m | — | — | — |
| Quarter to 30 Sep 2025 | 0.33 | Rs 200.4 m | — | — | — |
| Quarter to 31 Mar 2025 | 0.23 | Rs 392.3 m | — | — | — |
More on LPGL
- LPGL share price and overview
- Chemical sector
- NICL financials · Nimir Industrial Chemicals Limited
- NRSL financials · Nimir Resins Limited
- PAKOXY financials · Pakistan Oxygen Limited
- LCI financials · Lucky Core Industries Limited
- ICI financials · ICI Pakistan Limited
- LOTCHEM financials · Lotte Chemical Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .